focus -WSS

focus

author：entertainment 2025-10-02 11:38:29 - browse：2559

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： SAMSHA loosens regulations on methadone treatment centers

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Time to name cancers by genetics, not organ of origin, expert says

Do digital therapeutics have a future in medicine?

Some dementia cases could be undiagnosed liver disease

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

explore

focus

focus

Psychedelics group wrestles with new pharma identity

Medicare drug price negotiation’s day in court

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Heart attack and stroke risk calculators need revising

Amylyx ALS drug failure raises questions and concerns

ChatGPT in medicine: STAT answers readers' burning questions

Quicker fix for pulse oximeters urged during FDA public meeting

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Time to name cancers by genetics, not organ of origin, expert says

knowledge

Amylyx ALS drug failure raises questions and concerns

Juul spent big to court Black leaders to promote its e

CDC marks new Covid

Commercial surrogacy can be ethical, despite pope’s claims

Woodcock on FDA’s accelerated approval and her next chapter

First medicine developed to treat MASH expected to be approved soon

hotspot

hotspot

hotspot

entertainment